INTERVENE-HF: Feasibility Study of Individualized, Risk Stratification-Based, Medication Intervention in Patients with Heart Failure with Reduced Ejection Fraction

Abstract

The Intervene-HF study supports the feasibility of testing, in a large randomized clinical trial, an ambulatory medication intervention strategy that is physician-directed, CHFN-implemented, and based on individualized device risk stratification.